Further studies are required to assess whether FGF9 could serve as a prognostic factor in colon carcinoma and whether gene expression programs activated by FGF9 are implicated in the regulation of tumor cell adhesion, motility and metastasis in intestinal cancer. This evidence concerns the gene FGF9 and colon carcinoma.